Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples Post author:Sam Post published:March 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018 Journalist Sues FDA for Documents Related to Sarepta's DMD Drug May 25, 2017 Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial February 5, 2018
Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch January 14, 2018